In the BioHarmony Drug Report Database
Dimethyl fumarate
Tecfidera, Skilarence (dimethyl fumarate) is a small molecule pharmaceutical. Dimethyl fumarate was first approved as Tecfidera on 2013-03-27. It has been approved in Europe to treat multiple sclerosis and psoriasis. Tecfidera’s patents are valid until 2035-11-16 (FDA).
Trade Name
|
Skilarence, Tecfidera |
|---|---|
Common Name
|
dimethyl fumarate |
ChEMBL ID
|
CHEMBL2107333 |
Indication
|
multiple sclerosis, psoriasis |
Drug Class
|
Image (chem structure or protein)